Suppr超能文献

急性慢性肝衰竭:泰国人群多中心研究的流行病学、预后及结局

Acute-on-chronic liver failure: Epidemiology, prognosis, and outcome of a multicenter study in Thai population.

作者信息

Chirapongsathorn Sakkarin, Teerasarntipan Tongluk, Tipchaichatta Krit, Suttichaimongkol Tanita, Chamroonkul Naichaya, Bunchorntavakul Chalermrat, Siramolpiwat Sith, Chainuvati Siwaporn, Sobhonslidsuk Abhasnee, Leerapun Apinya, Piratvisuth Teerha, Sukeepaisarnjaroen Wattana, Tanwandee Tawesak, Treeprasertsuk Sombat

机构信息

Division of Gastroenterology Phramongkutklao Hospital and College of Medicine Bangkok Thailand.

Department of Medicine, Division of Gastroenterology, Faculty of Medicine Chulalongkorn University and Thai Red Cross Bangkok Thailand.

出版信息

JGH Open. 2022 Mar 10;6(3):205-212. doi: 10.1002/jgh3.12719. eCollection 2022 Mar.

Abstract

BACKGROUND AND AIM

Acute-on-chronic liver failure (ACLF) leads to multi-organ failure related to high mortality rates. This study aimed to gather epidemiological data and validate a scoring system to predict mortality in ACLF.

METHODS

This retrospective cohort study collected data from multicenter tertiary care hospitals in Thailand. A total of 638 hospitalized patients (acute decompensated liver disease [ADLD], 292 patients; ACLF, 346 patients) from January 2019 to June 2020 were enrolled in this study. We compared the mortality rate at days 30 and 90 between patients with ADLD and ACLF. Areas under the receiver operating characteristic (AUROC) curves of chronic liver failure-sequential organ failure assessment (CLIF-SOFA) and other existing scoring systems were compared among patients with ACLF.

RESULTS

The incidence of patients with ACLF was 54%. The main cause of chronic liver disease was alcohol (38%), with sepsis (50%) as the most common precipitating factor. ACLF with coagulopathy (AUROC 0.58, 95% confidence interval [CI]: 0.52-0.64), metabolic acidosis (AUROC 0.58, 95% CI: 0.52-0.64), and high aspartate aminotransferase (AST) (AUROC 0.59, 95% CI: 0.53-0.66) were associated with high 30-day mortality. The 30-day mortality rate of patients with acute decompensation and patients with ACLF was 46 and 58%, respectively. Respiratory system ( = 0.001) failure was the major end result in ACLF and constituted a significant factor to predict mortality. The AUROC of CLIF-SOFA score was superior to that of the other predicted score (AUROC 0.64, 95% CI: 0.585-0.704).

CONCLUSION

Patients with ACLF with more organ failure and high CLIF-SOFA score were associated with high short-term mortality. Future studies should include an ACLF prospective registry to confirm these finding.

摘要

背景与目的

慢加急性肝衰竭(ACLF)可导致多器官功能衰竭,死亡率很高。本研究旨在收集流行病学数据并验证一种预测ACLF患者死亡率的评分系统。

方法

这项回顾性队列研究收集了泰国多所三级医疗机构的数据。2019年1月至2020年6月期间,共有638例住院患者(急性失代偿性肝病[ADLD]患者292例;ACLF患者346例)纳入本研究。我们比较了ADLD患者和ACLF患者在第30天和第90天的死亡率。比较了ACLF患者中慢性肝衰竭序贯器官衰竭评估(CLIF-SOFA)及其他现有评分系统的受试者操作特征(AUROC)曲线下面积。

结果

ACLF患者的发病率为54%。慢性肝病的主要病因是酒精(38%),最常见的诱发因素是脓毒症(50%)。伴有凝血功能障碍(AUROC 0.58,95%置信区间[CI]:0.52 - 0.64)、代谢性酸中毒(AUROC 0.58,95% CI:0.52 - 0.64)和高天冬氨酸转氨酶(AST)水平(AUROC 0.59,95% CI:0.53 - 0.66)的ACLF患者30天死亡率较高。急性失代偿患者和ACLF患者的30天死亡率分别为46%和58%。呼吸系统衰竭(P = 0.001)是ACLF的主要终末结局,也是预测死亡率的重要因素。CLIF-SOFA评分的AUROC优于其他预测评分(AUROC 0.64,95% CI:0.585 - 0.704)。

结论

器官功能衰竭较多且CLIF-SOFA评分较高的ACLF患者短期死亡率较高。未来的研究应纳入ACLF前瞻性登记研究以证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1d/8938755/522285f3093e/JGH3-6-205-g020.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验